FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

702836004: Trastuzumab emtansine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2014. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3006212012 Trastuzumab emtansine en Synonym Active Entire term case insensitive SNOMED CT core module
3006214013 Trastuzumab emtansine (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trastuzumab emtansine Is a Trastuzumab false Inferred relationship Existential restriction modifier
Trastuzumab emtansine Has disposition Murine-human monoclonal immunoglobulin G antibody false Inferred relationship Existential restriction modifier
Trastuzumab emtansine Has disposition Immunomodulator true Inferred relationship Existential restriction modifier
Trastuzumab emtansine Is a Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier
Trastuzumab emtansine Has disposition Human epidermal growth factor receptor 2 inhibitor true Inferred relationship Existential restriction modifier
Trastuzumab emtansine Is a Murine-human monoclonal immunoglobulin G antibody false Inferred relationship Existential restriction modifier
Trastuzumab emtansine Is a Antineoplastic agent false Inferred relationship Existential restriction modifier
Trastuzumab emtansine Is modification of Trastuzumab false Inferred relationship Existential restriction modifier
Trastuzumab emtansine Is a Enzyme inhibitor protein true Inferred relationship Existential restriction modifier
Trastuzumab emtansine Is a Immunosuppressant true Inferred relationship Existential restriction modifier
Trastuzumab emtansine Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing trastuzumab emtansine (medicinal product) Has active ingredient True Trastuzumab emtansine Inferred relationship Existential restriction modifier 1
Trastuzumab emtansine Has active ingredient True Trastuzumab emtansine Inferred relationship Existential restriction modifier 1
Product containing trastuzumab emtansine in parenteral dose form (medicinal product form) Has active ingredient True Trastuzumab emtansine Inferred relationship Existential restriction modifier 1
Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form) Has active ingredient True Trastuzumab emtansine Inferred relationship Existential restriction modifier 1
Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has basis of strength substance True Trastuzumab emtansine Inferred relationship Existential restriction modifier 1
Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has precise active ingredient True Trastuzumab emtansine Inferred relationship Existential restriction modifier 1
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has basis of strength substance True Trastuzumab emtansine Inferred relationship Existential restriction modifier 1
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has precise active ingredient True Trastuzumab emtansine Inferred relationship Existential restriction modifier 1
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Trastuzumab emtansine Inferred relationship Existential restriction modifier 1
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Trastuzumab emtansine Inferred relationship Existential restriction modifier 1
Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Trastuzumab emtansine Inferred relationship Existential restriction modifier 1
Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Trastuzumab emtansine Inferred relationship Existential restriction modifier 1
Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has precise active ingredient True Trastuzumab emtansine Inferred relationship Existential restriction modifier 1
Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has basis of strength substance True Trastuzumab emtansine Inferred relationship Existential restriction modifier 1
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has precise active ingredient True Trastuzumab emtansine Inferred relationship Existential restriction modifier 1
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has basis of strength substance True Trastuzumab emtansine Inferred relationship Existential restriction modifier 1
Kadcyla 160mg powder for concentrate for solution for infusion vials (Originalis B.V.) Has specific active ingredient True Trastuzumab emtansine Inferred relationship Existential restriction modifier
Kadcyla 100mg powder for concentrate for solution for infusion vials (Originalis B.V.) Has specific active ingredient True Trastuzumab emtansine Inferred relationship Existential restriction modifier
Kadcyla 100mg powder for concentrate for solution for infusion vials (Originalis B.V.) 1 vial Has specific active ingredient True Trastuzumab emtansine Inferred relationship Existential restriction modifier
Kadcyla 160mg powder for concentrate for solution for infusion vials (Originalis B.V.) 1 vial Has specific active ingredient True Trastuzumab emtansine Inferred relationship Existential restriction modifier
Trastuzumab emtansine 100mg powder for solution for infusion vials Has specific active ingredient True Trastuzumab emtansine Inferred relationship Existential restriction modifier
Trastuzumab emtansine 160mg powder for solution for infusion vials Has specific active ingredient True Trastuzumab emtansine Inferred relationship Existential restriction modifier
Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) Has specific active ingredient True Trastuzumab emtansine Inferred relationship Existential restriction modifier
Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd) Has specific active ingredient True Trastuzumab emtansine Inferred relationship Existential restriction modifier
Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has specific active ingredient True Trastuzumab emtansine Inferred relationship Existential restriction modifier
Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has specific active ingredient True Trastuzumab emtansine Inferred relationship Existential restriction modifier
Trastuzumab emtansine 160mg powder for solution for infusion vials 1 vial Has specific active ingredient True Trastuzumab emtansine Inferred relationship Existential restriction modifier
Trastuzumab emtansine 100mg powder for solution for infusion vials 1 vial Has specific active ingredient True Trastuzumab emtansine Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start